Prohost Letter #410
JUNE PDUFA DAYS

This month, the FDA will decide on the approvals of drugs belonging to companies that Prohost has picked for investment. Usually, granting approvals rallies the stocks of the drugs’ developing firms. Sending Complete Response Letters for demands that might delay approvals would cut a substantial percentage of the stocks’ values, while rejections would cause the stocks to falter. Let’s have a look at the Prohost firms’ drugs whose PDUFA days are scheduled for June 2017 . . .